Zhibing Wu

1.3k total citations
65 papers, 960 citations indexed

About

Zhibing Wu is a scholar working on Biomedical Engineering, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhibing Wu has authored 65 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biomedical Engineering, 17 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhibing Wu's work include Nanoplatforms for cancer theranostics (10 papers), Ultrasound and Hyperthermia Applications (7 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Zhibing Wu is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Ultrasound and Hyperthermia Applications (7 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Zhibing Wu collaborates with scholars based in China, United States and Hong Kong. Zhibing Wu's co-authors include Yang Du, Jianjun Zheng, Peng Chen, Yao Li, Xiao Zhao, Wei Sun, Yanyun Wang, Xiaowei Ma, Lingyun Zhao and Haiming Fan and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Biomaterials.

In The Last Decade

Zhibing Wu

57 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhibing Wu China 18 326 304 148 121 118 65 960
Qianqian Liu China 18 166 0.5× 337 1.1× 68 0.5× 112 0.9× 89 0.8× 83 1.1k
Behnam Noorani United States 14 384 1.2× 527 1.7× 230 1.6× 82 0.7× 189 1.6× 27 1.7k
Mohammad S. Alavijeh United Kingdom 22 218 0.7× 419 1.4× 219 1.5× 60 0.5× 66 0.6× 50 1.5k
Jianhua He China 15 201 0.6× 287 0.9× 224 1.5× 160 1.3× 164 1.4× 29 935
Jia Shen China 17 275 0.8× 336 1.1× 76 0.5× 48 0.4× 79 0.7× 36 1.1k
Chen-Meng Qiao China 18 333 1.0× 545 1.8× 200 1.4× 123 1.0× 174 1.5× 35 1.2k
Xiaobin Zhou China 16 403 1.2× 404 1.3× 100 0.7× 93 0.8× 34 0.3× 35 1.1k
Qianqian Huang China 14 188 0.6× 507 1.7× 114 0.8× 154 1.3× 94 0.8× 41 935
Wenli Fang China 19 163 0.5× 339 1.1× 89 0.6× 182 1.5× 267 2.3× 38 1.2k

Countries citing papers authored by Zhibing Wu

Since Specialization
Citations

This map shows the geographic impact of Zhibing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhibing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhibing Wu more than expected).

Fields of papers citing papers by Zhibing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhibing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhibing Wu. The network helps show where Zhibing Wu may publish in the future.

Co-authorship network of co-authors of Zhibing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhibing Wu. A scholar is included among the top collaborators of Zhibing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhibing Wu. Zhibing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, He, Jianjun Lai, Yajun Wu, et al.. (2025). Arsenene-Vanadene nanodots co-activate Apoptosis/Ferroptosis for enhanced chemo-immunotherapy. Acta Biomaterialia. 196. 453–470.
2.
Zhang, Ling, Chen Wan, Yue Ding, et al.. (2025). Identification of new coumarin-cinnamic acid hybrid FtsZ inhibitors as potential bactericides for enhancing the yield and quality of rice. Food Chemistry. 495(Pt 3). 146505–146505. 1 indexed citations
3.
Li, Chengyu, Min Yang, Mengting Huang, et al.. (2025). Stabilization of AFF1 by PARylation ensures transcriptional restart after DNA damage. Nature Chemical Biology.
6.
Luo, Zhizeng, Lu Jiang, Chang Gao, et al.. (2024). Skin marker combined with surface‐guided auto‐positioning for breast DIBH radiotherapy daily initial patient setup: An optimal schedule for both accuracy and efficiency. Journal of Applied Clinical Medical Physics. 25(7). e14319–e14319. 3 indexed citations
7.
Wu, Yajun, Pengyuan Liu, Wendy Chen, et al.. (2024). Microwave hyperthermia enhances radiosensitization by decreasing DNA repair efficiency and inducing oxidative stress in PC3 prostatic adenocarcinoma cells. International Journal of Hyperthermia. 41(1). 2335201–2335201. 1 indexed citations
8.
Ye, Peng, He Li, Dandan Bao, et al.. (2024). Camouflaging nanoreactor traverse the blood-brain barrier to catalyze redox cascade for synergistic therapy of glioblastoma. Biomaterials. 311. 122702–122702. 6 indexed citations
9.
Xing, Wenmin, Wenyan Gao, Xiaoling Lv, et al.. (2023). Artificial intelligence predicts lung cancer radiotherapy response: A meta-analysis. Artificial Intelligence in Medicine. 142. 102585–102585. 8 indexed citations
11.
Chen, Peng, et al.. (2021). Alterations in the gut microbiota and metabolite profiles in the context of neuropathic pain. Molecular Brain. 14(1). 50–50. 57 indexed citations
12.
Lai, Lei, et al.. (2021). Polyphyllin I reverses the resistance of osimertinib in non-small cell lung cancer cell through regulation of PI3K/Akt signaling. Toxicology and Applied Pharmacology. 419. 115518–115518. 30 indexed citations
13.
Wang, Chen, et al.. (2021). Effects of varying degrees of ligation in a neuropathic pain model induced by chronic constriction injury. Life Sciences. 276. 119441–119441. 7 indexed citations
14.
Wu, Zhibing, et al.. (2021). A Hypopituitarism Patient with Bickerstaff's Brainstem Encephalitis Overlapped by Guillain-Barré Syndrome. Neurology India. 69(5). 1397–1399. 5 indexed citations
15.
Cheng, Ying, Dandan Bao, Xiaojie Chen, et al.. (2020). Microwave-triggered/HSP-targeted gold nano-system for triple-negative breast cancer photothermal therapy. International Journal of Pharmaceutics. 593. 120162–120162. 38 indexed citations
16.
Zhu, Lucheng, Yajun Wu, Pengyuan Liu, et al.. (2020). Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study. BMC Cancer. 20(1). 827–827. 10 indexed citations
17.
Liu, Xiaoli, Jianjun Zheng, Wei Sun, et al.. (2019). Ferrimagnetic Vortex Nanoring-Mediated Mild Magnetic Hyperthermia Imparts Potent Immunological Effect for Treating Cancer Metastasis. ACS Nano. 13(8). 8811–8825. 202 indexed citations
18.
Zhu, Lucheng, Zhibing Wu, & Shenglin Ma. (2019). Chemotherapeutic hyperthermic intraperitoneal perfusion following radical D2 resection in the treatment of advanced gastric cancer. Annals of Oncology. 30. iv5–iv6. 1 indexed citations
19.
Zhao, Yanyan, Shirong Zhang, Zhibing Wu, et al.. (2017). P2.05-029 Microwave Thermal Therapy Enhances Radiosensitivity of Highly Invasive Human Non-Small Cell Lung Cancer H460 Cells via Inhibiting DNA Repair. Journal of Thoracic Oncology. 12(1). S1048–S1048. 2 indexed citations
20.
Wu, Zhibing, et al.. (2007). Novel poly(fluorene-alt-squaraine) derivatives having large coverage with solar spectrum. e-Polymers. 7(1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026